WhatsApp Logo Subscribe
For News Alert

News

Coronavirus medicine remdesivir to be manufactured in Pakistan

May 13, 2020 05:41 PM


Twitter Share Facebook Share WhatsApp Share

BF Biosciences Limited (BFBL), a subsidiary of Ferozsons Laboratories Limited has successfully concluded its non-exclusive license agreement with Gilead Sciences, Inc. for the manufacture and sale of Remdesivir under Gilead’s Global Patient Solutions Programme serving the developing world, informed the company in a notice to the Pakistan Stock Exchange on Wednesday.

Remdesivir has been granted emergency use authorisation (EUA) by the US Food and Drug Administration (FDA) and authorities in Japan to treat hospitalised patients with severe COVID-19 disease.

The optimal duration of treatment is still being studied in ongoing clinical trials. Under the EUA, both 5-day and 10-day treatment durations are suggested, based on the severity of disease.

“Once production starts, we are confident that BFBL will have sufficient quantities over time to serve the needs of the patients in Pakistan and access countries abroad. BFBL management is actively taking up the matter with the relevant stakeholders for the necessary regulatory approvals and API arrangements so that Remdesivir is made available to patients on an urgent basis,” the notice added. 

Gilead has signed nonexclusive voluntary licenses agreements with five South Asian manufacturers – Hetero, Jubilant Lifesciences, Cipla, Mylan and BFBL – to manufacture Remdesivir for distribution in 127 countries.

Under the licensing agreements, the companies have a right to receive a technology transfer of the Gilead manufacturing process for Remdesivir to enable them to scale up production more quickly.

https://www.youtube.com/watch?v=pOavNaBX4NU


Most Read

  1. Two senior lawyers shot dead by Elite Force jawan in Attock court Two senior lawyers shot dead by Elite Force jawan in Attock court
  2. Bajwa-Khan bond 2.0: After Urvashi Rautela, Sonam Bajwa becomes Naseem Shah’s fan Bajwa-Khan bond 2.0: After Urvashi Rautela, Sonam Bajwa becomes Naseem Shah’s fan
  3. Sindh CM unveils ambitious Rs3.056 trillion budget for FY 2024-25 Sindh CM unveils ambitious Rs3.056 trillion budget for FY 2024-25
  4. PML-N MNA flees after coming face to face with Imran Khan PML-N MNA flees after coming face to face with Imran Khan
  5. LUMS secures third position at United Asians Debating Championship LUMS secures third position at United Asians Debating Championship
  6. Police arrest principal and MS Sahiwal hospital after children’s death in blaze Police arrest principal and MS Sahiwal hospital after children’s death in blaze

Opinion

  1. An Unmissable Opportunity: The Time for Modi and Islamabad leadership to Resume Bilateral Dialogue is Now!
    An Unmissable Opportunity: The Time for Modi and Islamabad leadership to Resume Bilateral Dialogue is Now!

    By Sudheendra Kulkarni

  2. Premier Shehbaz and Chinese model
    Premier Shehbaz and Chinese model

    By Naveed Aman Khan

  3. Modi's myth broken, yet in power
    Modi's myth broken, yet in power

    By Naveed Aman Khan

  4. Xi, Shehbaz and CPEC phase - 2
    Xi, Shehbaz and CPEC phase - 2

    By Naveed Aman Khan

  5. Pakistan's UNSC Triumph: A New Era
    Pakistan's UNSC Triumph: A New Era

    By Dr Asif Channer

  6. Shehbaz, Deng, Xi and transformation
    Shehbaz, Deng, Xi and transformation

    By Naveed Aman Khan